Cargando...
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
With conventional treatments for primary immunodeficiency diseases (PIDs), such as allogeneic stem cell transplantation or autologous gene therapy, still facing important challenges, the rapid development of genome editing technologies to more accurately correct the mutations underlying the onset of...
Guardado en:
| Publicado en: | Hum Gene Ther |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Mary Ann Liebert, Inc., publishers
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7612852/ https://ncbi.nlm.nih.gov/pubmed/32935622 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/hum.2020.185 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|